Portfolio company
VivoSense
United States · £19.8m raised
Raised
£19.8m
Latest stage
Series A
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops an informatics platform and digital biomarkers using wearable sensor data for life science researchers and pharmaceutical clinical trial sponsors.
SourceFunding history · 1
Similar companies
DEEP Measures
This company provides a platform for developing and validating digital biomarkers and endpoints for pharmaceutical companies and clinical research organisations.
VitalConnect
This company develops wearable biosensors for real-time remote patient monitoring and cardiac arrhythmia detection for hospitals, clinics and home healthcare providers.
Biobeat
This company develops wearable, cuffless vital sign monitoring devices and cloud-based analytics platforms for healthcare providers and clinical research organisations.
HumanFirst
This company provides a platform for life science organisations to evaluate and deploy digital measures for clinical trials and remote patient monitoring.
Xsensio
This company develops wearable biosensing chips for continuous biochemical monitoring of biomarkers to support healthcare providers and patients in clinical and wellness settings.
Biofourmis
This company develops artificial intelligence platforms and wearable sensors for remote patient monitoring and hospital-at-home services for health systems and pharmaceutical companies.
Empatica
This company develops medical-grade wearables and AI software for remote health monitoring, serving pharmaceutical companies, clinical researchers and healthcare providers.
Biomesense
This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.
